Related by context. All words. (Click for frequent words.) 73 MKC# MT 70 sodium thiosulfate STS 70 neuropathic pain metabolic diseases 68 investigational monoclonal antibody 68 Pimavanserin 68 includes investigational compounds 68 products MKC# PP 68 MKC# 68 immunological diseases 67 TELINTRA 67 JZP 67 HepeX B TM 67 selective immunoproteasome inhibitor 67 FOLOTYN ® 67 preclinical compounds 67 PI3K/Akt pathway inhibitor 67 Dacogen injection 67 including eniluracil ADH 67 YONDELIS 67 oncolytic virus therapies 67 proteasome inhibitor 67 AEG# 67 Evoltra ® 67 EndoTAG 67 novel VDA molecule 67 MKC# MKC# PP 67 Ceflatonin R 67 R roscovitine 67 elotuzumab 67 JAK inhibitors 67 oral prodrug 67 HyperAcute 67 seliciclib CYC# 66 Nanobody 66 RELOVAIR ™ 66 enzastaurin 66 interferon gamma 1b 66 investigational humanized monoclonal antibody 66 SinuNase TM 66 IMiDs 66 TÎ ² 4 66 JAK1 66 deforolimus 66 orally administered inhibitor 66 peptibody 66 Syncria 66 CYT# potent vascular disrupting 66 orally bioavailable mimics 66 Alocrest 66 Liprotamase 66 PDE4 inhibitor 66 sodium glucose cotransporter 66 Teplizumab 66 HCV polymerase inhibitors 66 JAK inhibitor 66 Combivir Kivexa 66 metaglidasen 66 IMA# 66 phase III isavuconazole 66 tiapamil 66 myeloproliferative disorders 66 cardio renal 66 ALN PCS 66 MEK inhibitors 66 Clolar ® 65 OHR/AVR# 65 Xcytrin R 65 orally bioavailable 65 Cetrorelix 65 pan HDAC inhibitor 65 IMiDs R 65 Rebif ® 65 LymphoStat B belimumab 65 myelofibrosis polycythemia vera 65 belinostat 65 Personalized Immunotherapy 65 TBC# 65 LymphoStat B TM 65 Panzem R 65 HuLuc# 65 CTLA4 Ig 65 diarrhea predominant irritable 65 formerly LymphoStat B 65 Mipomersen 65 investigational compound 65 Tezampanel 65 anticancer compounds 65 mertansine 65 ADP receptor antagonist 65 TREANDA 65 IgG1 monoclonal antibody 65 Tofacitinib 65 small molecule thrombopoietin 65 Cephalon Oncology 65 ALN HPN 65 liposomal formulation 65 DOS# 65 JAK2 inhibitor 65 PEG SN# 65 ulimorelin 65 humanized monoclonal antibody 65 2 methoxyestradiol 65 Quinamed R 65 PDX pralatrexate 65 docetaxel Taxotere R 65 Carfilzomib 65 Exelixis compounds 65 TRACON Pharmaceuticals 65 thalidomide Thalomid 65 RGB # 65 sapacitabine CYC# 65 HQK 65 AzaSite Xtra 65 lintuzumab SGN 65 axitinib 65 2 inhibitor CYT# 64 IMiD 64 NU# direct 64 Archexin 64 targeted radiotherapeutic 64 evaluating REVLIMID 64 mGluR5 negative 64 clinically validated targets 64 IAP inhibitors 64 Solazed TM 64 TRAIL receptor antibodies 64 rheumatoid arthritis psoriatic arthritis 64 CTAP# Capsules 64 PHX# 64 HCV protease inhibitors 64 SinuNase ™ 64 YONDELIS R 64 IV Busulfex 64 BAY #-# 64 leading oral taxane 64 selective androgen receptor modulators 64 HCV protease inhibitor 64 virus HCV protease inhibitor 64 gastrin analogue TT 64 forodesine 64 prokinetic agent 64 TLR9 agonist 64 cancer immunotherapies 64 Azedra 64 epothilones 64 RNAi therapeutic targeting 64 Ridaforolimus 64 investigational hepatitis C 64 Phase IIb clinical trials 64 AKT inhibitor 64 Dapagliflozin 64 fibrosis IPF 64 paclitaxel Taxol ® 64 PNP inhibitor 64 L BLP# 64 Janus kinase 64 gefitinib Iressa 64 Vidaza R 64 humanized anti 64 otelixizumab 64 thiazolides 64 inflammatory autoimmune diseases 64 Talabostat 64 BENLYSTA ® 64 PrevOnco ™ 64 PSN# [002] 64 psoriasis rheumatoid arthritis 64 selective modulator 64 bexarotene 64 GABITRIL 64 EndoTAG TM 64 Pazopanib 64 Tarmogen 64 Aflibercept 64 AFREZZA TM 64 huC# DM4 64 Chrysalin 64 oral ghrelin agonist 64 GW# [003] 64 rheumatoid arthritis thrombocytopenia 64 Symadex 64 erlotinib Tarceva ® 64 methylnaltrexone bromide 64 LUX Lung 64 phase IIb clinical 64 pan histone deacetylase 64 candidate CRLX# 63 Ganetespib 63 Lenocta 63 R sorafenib tablets 63 DU #b 63 sunitinib malate 63 gastrointestinal disorders ATI 63 5 HT6 63 non alcoholic steatohepatitis 63 drug ISA# 63 refractory gout 63 Sudhir Agrawal D.Phil 63 IL# PE#QQR 63 AAG geldanamycin analog 63 IMiDs ® 63 non nucleoside inhibitor 63 kidney urologic 63 neratinib 63 AzaSite Plus 63 Factor VIIa 63 Acute myeloid leukemia AML 63 TTR amyloidosis 63 prostone 63 relapsed leukemia 63 Neulasta ® 63 vaccines oncolytic virus 63 regorafenib 63 P#X# antagonist 63 tolevamer 63 essential thrombocythemia ET 63 TYZEKA 63 candidate deforolimus 63 hypoxia activated prodrug 63 panitumumab Vectibix 63 AEGR 63 Xanafide 63 PXD# 63 antibody MAb 63 Nexavar sorafenib 63 histone deacetylase HDAC inhibitor 63 Vandetanib 63 zileuton 63 cutaneous T 63 Sapacitabine 63 prasugrel CS 63 HCD# [002] 63 visilizumab 63 SAR# [002] 63 incyclinide 63 IMC #B 63 systemic juvenile idiopathic 63 romazarit 63 ENMD # 63 Quinamed 63 lexidronam injection 63 Adnectin 63 VEGF receptors 63 antiangiogenesis therapies 63 GVAX ® 63 LEUKINE 63 Daclizumab 63 reslizumab 63 SCH # 63 LUNESTA ® 63 multi kinase inhibitor 63 CDK cyclin dependent 63 Saxagliptin 63 vidofludimus 63 Oral NKTR 63 XL# XL# 63 DP VPA 63 registrational studies 63 THALOMID 63 hematological cancers 63 HGS ETR2 63 MTP inhibitor 63 Monopril 63 cetuximab Erbitux R 63 anticancer compound 63 rNAPc2 63 volociximab 63 telomerase therapeutic 63 oral proteasome inhibitor 63 MEK inhibitor 63 Myocet 63 HGS# 63 FUSILEV ® 63 Muraglitazar 63 RhuDex ® 63 alvespimycin 63 Bucindolol 63 Zolinza 63 Clofarabine 63 Selzentry Celsentri 63 hypertension osteoarthritis 63 Phase #/#a trial 63 Zybrestat 63 Aplidin R 63 beta interferons 63 immuno inflammatory diseases 63 AFRESA ® 63 investigational immunotherapy 63 sodium glucose transporter 63 MAGE A3 ASCI 63 oncology indications 63 Myelodysplastic syndromes MDS 63 Velcade bortezomib 63 Tyrima 63 vinca alkaloid 63 Raptiva R 63 MT# MEDI 63 pediatric acute lymphoblastic 63 ocular formulation 62 OvaRex ® MAb 62 antisense drug 62 rheumatoid arthritis multiple sclerosis 62 TACI Ig 62 chronic HCV infection 62 ELND-#/AZD-# 62 novel antibody therapeutics 62 PRT# 62 oral nucleoside analogue 62 INSPIRE Trial Phase III 62 Canvaxin TM 62 CDP# 62 Ostabolin C TM 62 eprotirome 62 preclinical efficacy 62 IMiDs ® compound 62 Thiarabine 62 Provectus Pharmaceuticals specializes 62 Aviptadil 62 Inhalation Solution 62 therapeutic monoclonal antibodies 62 Troxatyl 62 HGS ETR1 62 Proellex TM 62 PORxin TM 62 KSP inhibitor 62 Fludara ® 62 ZADAXIN ® 62 Vitaxin 62 THR beta agonist 62 HCV SPRINT 62 Neulasta R 62 Phase IIb trials 62 6R BH4 62 posaconazole 62 SERMs 62 Revimmune TM 62 oncolytic viruses 62 Zemiva TM 62 samarium Sm 62 constipation OIC 62 Hodgkin lymphoma HL 62 sJIA 62 XL# anticancer compounds 62 QUADRAMET R 62 Icatibant 62 demonstrated antitumor activity 62 Thalomid ® 62 calcineurin inhibitors 62 nucleoside analog 62 investigational therapies 62 XmAb ® 62 catheter occlusion 62 trastuzumab DM1 T DM1 62 Campath ® 62 GRNVAC1 62 Actimmune ® 62 Trastuzumab DM1 62 CD# antibody [001] 62 generation proteasome inhibitor 62 NNR Therapeutics 62 sorafenib tablets 62 Bendavia 62 delta opioid receptor 62 acyclovir Lauriad R 62 Traficet EN 62 lumiliximab 62 Zorbtive TM 62 PEGylated interferon beta 1a 62 multicenter Phase III 62 Randomized Phase 62 Allovectin 7 R 62 orally inhaled migraine 62 ASG 5ME 62 Romiplostim 62 rxRNA 62 BHT DNA 62 IRX 2 62 cathepsin K inhibitor 62 Prodarsan R 62 Onconase 62 LymphoStat B 62 talactoferrin 62 Zarnestra 62 Aganocide 62 Granisetron 62 VEGFR2 inhibitor 62 Inotek Pharmaceuticals Corporation 62 LHRH antagonists 62 Didronel 62 beta 1a 62 Ocrelizumab 62 Vicinium TM 62 selective kinase inhibitor 62 receptor tyrosine kinase inhibitor 62 neovascular diseases 62 HuMax CD4 62 dasatinib Sprycel ® 62 Ixempra 62 BXT # 62 VISICOL R 62 cetuximab Erbitux 62 NP2 Enkephalin 62 SPRYCEL ® 62 generation purine nucleoside 62 rheumatoid arthritis psoriasis 62 systemic fungal infections 62 castrate resistant prostate cancer 62 Atrasentan 62 topical anti infective 62 Bazedoxifene 62 gastro intestinal inflammation 62 isoform selective 62 novel oral anticoagulant 62 urocortin 2 62 midstage studies 62 Eltrombopag 62 Marqibo TM 62 TLR9 agonists 62 NTDDS 62 ularitide 62 serine protease inhibitor CU# 62 daclizumab 62 Homspera TM 62 toenail onychomycosis 62 Litx 62 teplizumab 62 PORxin TM platforms 62 muscarinic receptor agonist 62 PDE# inhibitors 62 anti CD# antibodies 62 pharmacokinetic PK study 62 induced macular edema 62 monoclonal antibody therapeutics 62 ancrod 62 oncology therapeutics 62 sorafenib Nexavar 62 phase IIb trial 62 ATL# [001] 62 Shigamabs ® 62 Elagolix 62 DPP4 inhibitor 62 Vicriviroc 62 depsipeptide 62 IMC A# 62 Tanespimycin 62 ISIS # 62 CD3 monoclonal antibody 62 Sutent sunitinib 62 Lu AA# 62 novel peptide 62 cognitive impairment associated 62 etanercept Enbrel 62 HIV integrase inhibitors 62 hepatitis C HCV 62 cardiometabolic disorders 62 Cytogen marketed 62 Nexavar ® 62 polymerase inhibitors 62 Diamyd ® 62 Insegia 62 hypereosinophilic syndrome 62 targeted antifolate 62 topical gel formulation 62 Luveris R Ovidrel R 62 tranilast 62 PEG Interferon lambda 62 labial herpes 62 cardiovascular metabolic 62 CRLX# 62 Synavive ™ 62 R#/MEM # 62 Behcet uveitis 62 Vernakalant 62 Anidulafungin 62 midstage clinical 62 YM AIM YMBA 62 Prodarsan ® 62 Janus Kinase 62 fluoroquinolone antibiotic 62 metformin HCl 62 Campath alemtuzumab 62 Tarceva TM 62 angiogenesis inhibitor 61 Interferon alpha 61 infliximab Remicade 61 vaccine GRNVAC1 61 sarcoma melanoma 61 treatment naïve genotype 61 BCR ABL inhibitors 61 platforms GVAX 61 Phase #b/#a clinical 61 Omacetaxine 61 Exherin TM 61 trastuzumab Herceptin R 61 AFREZZA ™ 61 novel histone deacetylase 61 Abbokinase 61 EOquin TM phase 61 intranasal formulation 61 brivanib 61 pomalidomide 61 Sym# 61 DDP# 61 histone deacetylase HDAC 61 MCSP respectively 61 interferon alfacon 1 61 glucokinase activator 61 Virulizin ® 61 Cleviprex TM clevidipine 61 MT#/MEDI-# 61 placebo controlled Phase 61 cyclophilin inhibitors 61 darinaparsin ZIO 61 Squalamine 61 ALN TTR 61 NXL# 61 rasagiline tablets 61 microtubule inhibitor 61 dermatology therapies 61 ARRY # 61 Serdaxin 61 INCB# [001] 61 MGd 61 refractory chronic lymphocytic 61 entinostat 61 Tasimelteon 61 immune globulin intravenous 61 Microplasmin 61 refractory metastatic 61 somatostatin analogue 61 cilengitide 61 CCR9 antagonist 61 humanized interleukin 6 61 Vaccine Recombinant 61 tasocitinib 61 Targretin 61 thrombin inhibitor 61 candidate AQ4N 61 oral dual endothelin 61 phenylalanine ammonia lyase 61 leukemia AML 61 A3 adenosine receptor 61 inflammatory autoimmune 61 ALGRX 61 adalimumab Humira 61 Eraxis 61 Inc. AMEX YMI 61 TKB# 61 PKC# 61 CR# vcMMAE 61 hematologic disorders 61 polycythemia vera PV 61 benign prostatic hypertrophy BPH 61 oncological indications 61 multitargeted 61 MGCD# [001] 61 rheumatoid arthritis inflammatory bowel 61 selective phosphodiesterase 61 MyVax R 61 HuMax TAC 61 OncoVEX GM CSF 61 paclitaxel Taxol 61 PRTX 61 addressing idiopathic pulmonary 61 compound INCB# 61 ospemifene 61 fusion enhancers 61 highly selective adenosine 61 Panzem R NCD 61 CD# CEA 61 oncologic diseases 61 myeloproliferative neoplasms MPNs 61 VEGF inhibitors 61 MEK Inhibitor 61 Phase 2b clinical trials 61 squalamine 61 R Saizen R 61 REMINYL ® 61 telomerase inhibitor drug 61 Epratuzumab 61 AVE# 61 JVRS 61 Safinamide 61 XmAb# 61 oral picoplatin 61 VQD 61 oral Hsp# inhibitor 61 ionotropic glutamate receptor antagonists 61 PLK1 SNALP 61 zanolimumab 61 IL# PE 61 verteporfin 61 Selective Electrochemical Tumor Ablation 61 therapeutic monoclonal antibody 61 vapreotide acetate 61 Ixabepilone 61 tramiprosate Alzhemed TM 61 Synavive 61 erlotinib Tarceva 61 chimeric monoclonal antibody 61 compound PMX # 61 TG# [003] 61 investigational pan BCR 61 alpha interferons 61 Genentech Rituxan 61 EOquin TM 61 STELARA TM 61 Onco TCS 61 PSMA ADC 61 Oxytrol R 61 Allovectin 7 ® 61 LibiGel ® 61 PEGylated Fab fragment 61 Cancidas 61 Presents Preclinical 61 Navelbine ® 61 NV1FGF 61 ChronVac C R 61 HuMax CD# 61 GKAs 61 Albugon 61 Aurexis 61 Rigel R# 61 EnzymeRx 61 acting muscarinic antagonist 61 selective S#P# receptor agonist 61 Zavesca r 61 Pivotal Phase 61 dextromethorphan quinidine 61 valent pneumococcal conjugate vaccine 61 Lubiprostone 61 HER2 positive metastatic breast 61 terlipressin 61 myeloproliferative diseases 61 ABILIFY ® 61 Initiates Phase II 61 idiopathic thrombocytopenic purpura ITP 61 Telik logo TELINTRA 61 TransVax ™ 61 kinase inhibitor 61 pioglitazone HCl 61 mitogen activated ERK kinase 61 OXi# 61 imatinib Gleevec ® 61 SUPPRELIN R LA 61 Phase 2b Clinical Trial 61 Pemetrexed 61 anticoagulant reversing agent 61 Ceflatonin 61 endothelin antagonist 61 PEGylated 61 pralatrexate injection folate analogue 61 Cx# [002] 61 Temsirolimus 61 IAP inhibitor 61 GERD migraine headaches 61 Gleevec imatinib mesylate 61 Intermezzo ® zolpidem tartrate 61 rheumatoid arthritis juvenile idiopathic 61 autoimmune inflammatory 61 Azedra TM 61 oral JAK1 61 Tovaxin ® 61 COLAZAL R 61 antisense drugs 61 tumor xenograft models 61 GSK # 61 Onalta ™ 61 Genasense ® oblimersen 61 aripiprazole Abilify 61 nalbuphine ER 61 Phase IIa trials 61 include PLX IBD 61 derivatives Radilex TM 61 post herpetic neuralgia PHN 61 LY# [003] 61 sapropterin dihydrochloride 61 molecular imaging radiopharmaceutical 61 vascular disrupting agents 61 modified glutathione analog 61 darapladib 61 histone deacetylase inhibitor 61 immune modulating 61 Zavesca R 61 agonist compounds 61 acetonide FA 61 pancreatic neuroendocrine tumors 61 RezularTM 61 rALLy clinical trial 61 Hedgehog Pathway Inhibitor 61 Cannabinor 61 Remicade infliximab 61 INCB# [003] 61 RhuDex R 61 GVAX R 61 ZOLINZA 61 BRAF inhibitor 61 rheumatoid arthritis Crohn disease 61 trastuzumab emtansine T DM1 61 VitiGam 61 Fabry Disease 61 lasofoxifene 61 receptor inhibiting monoclonal 61 Granulocyte Colony Stimulating Factor 61 torezolid phosphate 61 RNAi therapeutic 61 MPS IVA 61 brivaracetam 61 synthetic retinoid 61 MORAb 61 insulin sensitizers 61 personalized cellular immunotherapy 61 itraconazole Sporanox 61 CRTH2 61 RNA antagonists 61 ONCONASE R 61 Ostarine ™ 61 Nasdaq HALO biopharmaceutical 61 Allovectin 7 61 multicenter Phase II 61 catalytic antioxidant compounds 61 NovaBay Aganocide compounds 61 Triolex 61 INxin TM 61 Phase Ib study 61 Completes Patient Enrollment 61 tanespimycin 61 Ozarelix 61 immunotherapeutic approaches 61 hematological malignancies 61 Firazyr 61 Inc. NASDAQ AEZS 61 essential thrombocythemia 61 Voreloxin 61 dipeptidyl peptidase 4 61 muraglitazar 61 arzoxifene 61 intranasal insulin product 61 Glufosfamide 61 XL# XL# XL# 61 Pirfenidone 61 JAK3 61 thymalfasin 61 Arcalyst 61 renin inhibitors 61 Annamycin 61 evaluating satraplatin 61 PRECiSE 61 evaluating tivozanib 61 Axitinib 61 targeting CD# 61 topical formulations 61 PROSTVAC TM 61 hematological indications 61 LY# [002] 61 Myolimus 61 Phase 2a Clinical Trial 61 Gleevec Glivec 61 EndoTAG TM -1 61 SYN# 61 Hsp# inhibition 61 Pegasys peginterferon alfa 2a 61 novel DACH platinum 61 Nanobodies 61 Boniva ibandronate 61 Cimzia TM 61 Nasdaq MITI biopharmaceutical 61 lomitapide 60 RNAi therapeutic targeting PCSK9 60 Vaprisol 60 Amgen Enbrel 60 Radezolid 60 dalbavancin 60 Vascugel 60 Optiquel ™ 60 histone deacetylase 60 drug pipeline TAFA# 60 antisense inhibitors 60 PEG PAL PEGylated recombinant 60 MERREM 60 Loceryl ® 60 brand ciclesonide HFA 60 RhuDex TM 60 Hsp# Inhibitor 60 immunologic diseases 60 Iluvien ® 60 TRANSDUR ® 60 Ambrisentan 60 treat refractory angina 60 candidate XP# 60 HDAC Inhibitor 60 Cloretazine 60 Prestara 60 SUVN 60 trial evaluating PRX# 60 Azacitidine 60 FACTIVE R gemifloxacin 60 Xyfid TM 60 PPAR gamma agonists 60 DPX Survivac 60 Enbrel etanercept 60 Crofelemer budesonide foam 60 oral taxane 60 Serdaxin ® 60 vesicular monoamine transporter 60 Laquinimod 60 Trofex TM 60 Reverset 60 Oracea TM 60 Letairis ambrisentan 60 Orally administered 60 PPAR gamma agonist 60 Nanobody R 60 5 HT3 antagonist 60 oral Factor Xa 60 cannabinor 60 thetreatment 60 humanised monoclonal antibody 60 TNF Tumor Necrosis Factor 60 nebulized budesonide 60 chronic eosinophilic leukemia 60 evaluating picoplatin 60 NS5b 60 HuMax 60 Abiraterone acetate 60 HMG CoA reductase inhibitors 60 HIV integrase inhibitor 60 docetaxel Taxotere ® 60 treatment naive genotype 60 Intarcia 60 nosocomial pneumonia 60 romiplostim 60 transthyretin TTR mediated amyloidosis 60 pharmacological chaperone 60 rheumatoid arthritis psoriasis Crohn 60 anti CD3 monoclonal 60 radezolid 60 novel immunomodulatory 60 Amrubicin 60 HuMax EGFr 60 Akt inhibitor 60 PrevOnco 60 familial amyloidotic polyneuropathy FAP 60 histone deacetylase HDAC inhibitors 60 neuropathic pain spasticity 60 anti amnesic 60 Diabetic Macular Edema 60 MOVIPREP R 60 nucleotide analogues 60 metastatic neuroendocrine tumors 60 ALK inhibitor 60 mapatumumab 60 Namenda ® 60 ALN VSP Phase 60 non nucleoside HCV 60 Phase Ib 60 lapatinib Tykerb 60 ATPace TM 60 allosteric modulator 60 Phase 2a trial 60 oxaliplatin Eloxatin 60 HSP# inhibitor 60 eniluracil 60 AZILECT ® 60 INS# [001] 60 Tarvacin TM 60 registrational trials 60 oral ridaforolimus 60 small molecule activators 60 intranasal delivery 60 randomized controlled Phase 60 compound ITMN 60 Viprovex TM 60 cMET 60 novel therapeutic antibodies 60 novel topoisomerase 60 Hyphanox 60 phase IIa clinical 60 HCV NS5B polymerase 60 EGFR HER2 60 Plicera 60 cediranib 60 NASDAQ ABII 60 Vidaza azacitidine 60 cosmetic cosmeceutical products 60 subcutaneous formulation 60 crizotinib PF # 60 novel RNAi therapeutics 60 BiovaxID TM 60 E1 INT TM 60 DermaVir Patch 60 Aryplase 60 prucalopride 60 ROTATEQ 60 omega interferon 60 developing Bicifadine serotonin 60 Targeted Chemotherapy 60 Aplidin 60 Leukine 60 TRV# [001] 60 myasthenia gravis Huntington 60 MOZOBIL 60 Tumour Vascular Disrupting Agent 60 selective inhibitor 60 dasatinib Sprycel 60 STEDESA 60 personalized immunotherapy 60 selective inhibition 60 receptor modulators 60 alfimeprase direct 60 Entereg R 60 bortezomib Velcade 60 GAMMAGARD 60 dihydrochloride 60 retinal vein occlusion induced 60 Ilaris 60 Phase Ib II 60 TRO# 60 Solazed 60 Amplimexon 60 Aurexis R 60 ThermoDox ® clinical 60 acute peripheral arterial 60 IPL# 60 beta secretase inhibitors 60 methylnaltrexone 60 relapsed MM 60 BENCHMRK 60 tafamidis 60 nucleoside analogues 60 lucinactant 60 commercializing anti infective 60 Onalta TM 60 Civacir 60 Amigal 60 Leukine ® 60 TRIOLEX HE# 60 antiviral therapeutics 60 markets HP Acthar 60 ESBA# 60 oral antiviral 60 Revimmune 60 Starlix 60 Tovaxin TM 60 ganetespib 60 TSX YM AIM 60 lymphoid malignancies 60 Treanda 60 Kepivance 60 multiple sclerosis rheumatoid arthritis 60 anti CD3 antibody 60 ThermoDox R 60 anti infective ophthalmic 60 Proxinium TM 60 Enkephalin 60 XP# XP# 60 IgG1 antibody 60 immuno modulatory 60 granisetron formulated 60 monoclonal antibody MAb 60 CYC# 60 Potelligent Technology 60 Epothilones 60 SAR# [004] 60 BioNumerik 60 relapsed multiple myeloma 60 octreotide implant 60 RAPTIVA 60 ixabepilone 60 SIRT1 activators 60 trastuzumab DM1 60 Zometa zoledronic acid 60 CCR5 mAb 60 Twinject ® 60 Soliris eculizumab 60 Anticalins 60 Azilect ® 60 Valopicitabine 60 Octreolin 60 antithrombotic agents 60 BRILINTA 60 Maribavir 60 teriflunomide 60 pertuzumab 60 DiaPep# 60 HZT 60 Seliciclib 60 BiTE R 60 Bezielle 60 Amgen Neulasta R 60 ApoB SNALP 60 Vectibix panitumumab 60 cancer neuroendocrine tumor 60 nitric oxide donating prostaglandin 60 dextofisopam 60 MNTX 60 CRx 60 SNRI 60 Tesetaxel